Drug Type Small molecule drug |
Synonyms A31S, mycosinate+Hydrogen Peroxide (Nektr Techonologies) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Onychomycosis | Preclinical | IE | 07 Jun 2019 | |
Enterococcus faecium infection | Preclinical | IE | - | |
Escherichia Coli Infections | Preclinical | IE | - | |
Gonorrhea | Preclinical | IE | - | |
Infection due to carbapenem resistant Acinetobacter | Preclinical | IE | - | |
Klebsiella Infections | Preclinical | IE | - | |
Pseudomonas Infections | Preclinical | IE | - | |
Staphylococcal Infections | Preclinical | IE | - | |
Streptococcal Infections | Preclinical | IE | - |